Cargando…
Comparative Effect of Curcumin and Nanocurcumin on Nephroprotection at Cisplatin-induced Rats
BACKGROUND: Cisplatin is a first-line chemotherapeutic agent for various solid tumors including ovarian and breast cancer. Thereby, it has been proven effective as an antineoplastic agent, but its clinically use is limited because of its nephrotoxicity side effect. AIMS AND OBJECTIVES: This study ai...
Autores principales: | Sandhiutami, Ni Made D., Arozal, Wawaimuli, Louisa, Melva, Rahmat, Deni, Mandy, Tjoeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020831/ https://www.ncbi.nlm.nih.gov/pubmed/32148365 http://dx.doi.org/10.4103/jpbs.JPBS_208_19 |
Ejemplares similares
-
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA
por: Sandhiutami, Ni Made Dwi, et al.
Publicado: (2021) -
Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats
por: Louisa, Melva, et al.
Publicado: (2023) -
Development, Characterization and Pharmacokinetic Profile of Chitosan-Sodium Tripolyphosphate Nanoparticles Based Drug Delivery Systems for Curcumin
por: Arozal, Wawaimuli, et al.
Publicado: (2021) -
Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration
por: Barinda, Agian Jeffilano, et al.
Publicado: (2022) -
Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies
por: Arozal, Wawaimuli, et al.
Publicado: (2020)